Retrophin, Inc. Uncategorized Contracts & Agreements

15 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 5 to Sublicense Agreement, dated as of March 20, 2018, between the Company and Ligand Pharmaceuticals Incorporated
Retrophin, Inc.
Biotechnology
NY
2024
Amended and Restated Open Market Sale Agreement, dated October 31, 2024, by and between the Company and Jefferies LLC
Retrophin, Inc.
Biotechnology
NY
2024
The Company's 202
Retrophin, Inc.
Biotechnology
2024
Amendment No. 4 to Sublicense Agreement dated as of September 17, 2015, between the Company and Ligand Pharmaceuticals Incorporated
Retrophin, Inc.
Biotechnology
NY
2022
Amendment No. 3 to Sublicense Agreement dated as of February 27, 2015, between the Company and Ligand Pharmaceuticals Incorporated
Retrophin, Inc.
Biotechnology
NY
2022
Amendment No. 5 to Sublicense Agreement dated as of March 20, 2018, between the Company and Ligand Pharmaceuticals Incorporated
Retrophin, Inc.
Biotechnology
NY
2018
Form of Indemnity Agreement
Retrophin, Inc.
Biotechnology
DE
2018
AMENDMENT NO. 4 TO SUBLICENSE AGREEMENT
Retrophin, Inc.
Biotechnology
NY
2015
AMENDMENT NO. 3 TO SUBLICENSE AGREEMENT
Retrophin, Inc.
Biotechnology
NY
2015
Summary SeparationProposal
Retrophin, Inc.
Biotechnology
NY
2015
SPONSORED RESEARCH AGREEMENT
Retrophin, Inc.
Biotechnology
CA
2013
SPONSORED RESEARCH AGREEMENT
Retrophin, Inc.
Biotechnology
NY
2013
[MSMB LETTERHEAD]
Retrophin, Inc.
Biotechnology
2013
SPONSORED RESEARCH AGREEMENT
Retrophin, Inc.
Biotechnology
NY
2013
SUBLICENSE AGREEMENT
Retrophin, Inc.
Biotechnology
NY
2012